PREDNISOLONE ENCAPSULATED SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES FOR TARGET DRUG DELIVERY – DESIGN AND QUANTIFICATION

Authors

  • SUBASHINI RAJARAM Department of Pharmaceutics and Research, Swamy Vivekanandha College of Pharmacy (Tamil Nadu DR. M.G.R. Medical University, Chennai),Namakkal, Tamil Nadu, India.
  • SENTHIL RAJAN DHARMALINGAM Department of Pharmaceutics and Research, Swamy Vivekanandha College of Pharmacy (Tamil Nadu DR. M.G.R. Medical University, Chennai),Namakkal, Tamil Nadu, India.
  • SANTHOSE RANI A Department of Pharmaceutics and Research, Swamy Vivekanandha College of Pharmacy (Tamil Nadu DR. M.G.R. Medical University, Chennai),Namakkal, Tamil Nadu, India.
  • SAPTHASRI R Department of Pharmaceutics and Research, Swamy Vivekanandha College of Pharmacy (Tamil Nadu DR. M.G.R. Medical University, Chennai),Namakkal, Tamil Nadu, India.
  • VARSHA D Department of Pharmaceutics and Research, Swamy Vivekanandha College of Pharmacy (Tamil Nadu DR. M.G.R. Medical University, Chennai),Namakkal, Tamil Nadu, India.
  • VINODHINI V Department of Pharmaceutics and Research, Swamy Vivekanandha College of Pharmacy (Tamil Nadu DR. M.G.R. Medical University, Chennai),Namakkal, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2019.v12i11.35439

Keywords:

Superparamagnetic iron oxide nanoparticles, Prednisolone, Colon target drug delivery system, Polyethylene glycol, Coprecipitation method, Double emulsion method

Abstract

Objective: The present study aimed to develop a novel type of superparamagnetic iron oxide nanoparticles (SPIONs) to deliver prednisolone at colon as a target site for the treatment of inflammatory bowel disease (IBD) such as ulcerative colitis and Crohn’s disease which may further progress to cancer.

Methods: SPIONs were synthesized using a coprecipitation method. Further, it was encapsulated with prednisolone-polyethylene glycol by double emulsion method (W1/O/W2). The prepared formulations were characterized for its physicochemical characterization such as scanning electron microscopy, X-ray diffraction, particle size and zeta potential, encapsulation efficiency, and in vitro drug release.

Results: The results reveal that the physicochemical property of the formulations complies with the standard values and in vitro release of prednisolone in the first 18 h, attains 57 and 58% and it reaches 71 and 75% at 24 h, and this is statistically significant (p˂0.0177). This release result implies that the drug release from the formulations is controllable and sustains manner.

Conclusion: Our findings could be a promising approach for the delivery of prednisolone with enhanced half-life for the treatment of IBD through colon targeting.

Downloads

Download data is not yet available.

References

Manish G, Vimukta S. Targeted drug delivery system: A review. Res J Chem Sci 2011;1:135-8.

Philip AK, Philip B. Colon targeted drug delivery systems: A review on primary and novel approaches. Oman Med J 2010;25:79-87.

Ben MS, Marina K, Mukund GS. Eudragit S-100 encapsulated chitosan coated liposomes containing prednisolone for colon targeting: In vitro, ex vivo and in vivo evaluation. J Young Pharm 2019;11:7-11.

Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy. Adv Drug Deliv Revi 2011;63:24-46.

Nagesh PK, Johnson NR, Boya VK, Chowdhury P, Othman SF, Khalilzad-Sharghi V, et al. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer. Colloids Surf B Biointerfaces 2016;144:8-20.

Ostenfeld EB, Erichsen R, Thorlacius-Ussing O, Riis AH. Use of systemic glucocorticoids and the risk of colorectal cancer. Aliment Pharmacol Ther 2013;37:146-52.

Kumria R, Nair AB, Goomber G, Gupta S. Buccal films of prednisolone with enhanced bioavailability. Drug Deliv 2016;23:471-8.

Nidhi JS, Anand R, Rahul M, Suman R. Design and characterization of dual drug loaded microspheres for colon drug targeting. J Drug Deliv Ther 2019;9:12-22.

Reddy KR, Begum HR, Harsha GS, Srikar N, Anil K. Preparation and in-vitro evaluation of prednisolone mucoadhesive tablets for colon targeted drug delivery system. Int J Innov Pharm Res 2015;6:485-90.

Hamzian N, Hashemi M, Ghorbani M, Toosi MH, Ramezani M. Preparation, optimization and toxicity evaluation of (SPION-PLGA)±PEG nanoparticles loaded with gemcitabine as a multifunctional nanoparticle for therapeutic and diagnostic applications. Iran J Pharm Res 2017;16:8-21.

Goyal P, Rani D, Chadha R. Exploring structural aspects of nateglinide polymorphs using powder X-ray diffraction. Int J Pharm Pharm Sci 2017;9:119-27.

Justin C, Philip SA, Samrot AV. Synthesis and characterization of superparamagnetic iron-oxide nanoparticles (SPIONs) and utilization of SPIONs in X-ray imaging. Appl Nanosci 2017;7:463-75.

Saraogi GK, Gupta P, Gupta UD, Jain NK, Agrawal GP. Gelatin nanocarriers as potential vectors for effective management of tuberculosis. Int J Pharm 2010;385:143-9.

Mothilal M, Krishna MC, Teja SP, Manimaran V, Damodharan N. Formulation and evaluation of naproxen-eudragit® Rs 100 nano suspension using 32 factorial design. Int J Pharm Pharm Sci 2014;6:449-55.

Mora CH, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm 2010;385:113-42.

D’Souza SS, DeLuca, PP. Methods to assess in-vitro drug release from injectable polymeric particulate systems. Pharm Res 2006;23:460-74.

D’Souza SS, DeLuca PP. Development of a dialysis in-vitro release method for biodegradable microspheres. AAPS PharmSciTech 2005;6:E323-8.

Published

07-11-2019

How to Cite

SUBASHINI RAJARAM, SENTHIL RAJAN DHARMALINGAM, SANTHOSE RANI A, SAPTHASRI R, VARSHA D, and VINODHINI V. “PREDNISOLONE ENCAPSULATED SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES FOR TARGET DRUG DELIVERY – DESIGN AND QUANTIFICATION”. Asian Journal of Pharmaceutical and Clinical Research, vol. 12, no. 11, Nov. 2019, pp. 126-31, doi:10.22159/ajpcr.2019.v12i11.35439.

Issue

Section

Original Article(s)